CD8A and hepatocellular carcinoma: A more in-depth analysis showed that, starting from the third-week post transplantation, subjects who will develop HCC recurrence have a significant expansion of T14 (a subtype of γδ T lymphocytes) and T21 subpopulations (a subtype of CD8+ T cells) compared with patients who will not develop HCC recurrence [53].